Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Expert Opinion on Drug Safety|May 16, 2019
Disproportionality analysis of bullous pemphigoid adverse events with PD-1 inhibitors in the FDA adverse event reporting systemPushkar AggarwalTherapeutic Advances in Drug Safety|August 28, 2019
Risk of bronchospasm and coronary arteriospasm with sugammadex use: a post marketing analysisPushkar AggarwalDermatologic Therapy|January 12, 2020
Pyoderma gangrenosum adverse event with Rituximab use: A postmarketing pharmacovigilance analysisPushkar AggarwalJMIR Dermatology|August 26, 2023
Performance of Artificial Intelligence Imaging Models in Detecting Dermatological Manifestations in Higher Fitzpatrick Skin Color ClassificationsPushkar AggarwalJournal of Infection in Developing Countries|December 17, 2009
Passive immunity to pandemic H1N1 2009 by swine flu partiesNitish Aggarwal, Pushkar AggarwalJournal of Drugs in Dermatology : JDD|December 5, 2022
Immune-Response Modifiers: Characteristics of High-Volume PrescribersPushkar Aggarwal, Alan FleischerSkin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|May 30, 2019
Data augmentation in dermatology image recognition using machine learningSt Lt Pushkar AggarwalJournal of Clinical Medicine|September 14, 2024
IL-17 and IL-23 Inhibitors Have the Fastest Time to Meaningful Clinical Response for Plaque Psoriasis: A Network Meta-AnalysisPushkar Aggarwal, Alan B FleischerThe Journal of Dermatological Treatment|June 22, 2021
Artificial intelligence image recognition of melanoma and basal cell carcinoma in racially diverse populationsPushkar Aggarwal, Francis A PapayJMIR Dermatology|October 30, 2024
Photosensitivity From Avapritinib: Pharamacovigilance AnalysisAjit Venkatakrishnan, Brandon Chu, Pushkar AggarwalPageof 2